Resources

Flying Blind: unveiling the patchy landscape of global R&D for endometriosis, polycystic ovary syndrome and uterine fibroids

Impact Global Health

Summarizes global R&D funding, product pipelines, and innovation gaps for endometriosis, PCOS, and uterine fibroids to inform investment and accelerate women’s health progress.

For Data’s Sake: Dilemmas in the Measurement of Gender Minorities

Glick, J. L. et al.

Summarizes dilemmas in measuring gender minorities for health research, providing insights to improve data collection and address health disparities in the USA.

Frascati Manual 2015: Guidelines for Collecting and Reporting Data on Research and Experimental Development

OECD

Provides internationally agreed guidelines for collecting, classifying, and reporting R&D data to support policy development, analysis, and international comparability.

From Margins to Momentum: An AI-Enabled Transformation in Women’s Health

Sehat, B., et al.

Summarizes AI's role in addressing data gaps, bias, and underinvestment in women's health to improve diagnosis, care, and health outcomes.

Fusobacterium Infection Facilitates the Development of Endometriosis through the Phenotypic Transition of Endometrial Fibroblasts

Muraoka, A. et al.

Provides information on the role of Fusobacterium infection in promoting endometriosis development and suggests antibiotic treatment as a potential therapeutic approach.

G-FINDER

Impact Global Health

Provides data visualizations and downloadable datasets on global funding flows for sexual and reproductive health R&D, supporting analysis and decision-making in health research investments.

Gender Differences in Cardiometabolic Health And Disease in a Cross-Sectional Observational Obesity Study

Strack, C., et al.

Provides information on sex differences in body fat distribution and their impact on cardiometabolic risk and metabolic syndrome prevalence in obesity research.

Gender Differences in Clinical Registration Trials: Is There a Real Problem? 

Labots, G. et al.

Reviews data on gender representation in FDA drug trials to assess under-representation of women and its implications for drug approval decisions.

Gender Differences in Depression: Critical Review

Piccinelli, M. & Wilkinson, G. 

Reviews data on gender differences in depression, examining risk factors and determinants to clarify why prevalence is higher in females than males.

Gender Disparity in the Funding of Diseases by the U.S. National Institutes of Health

Mirin, A. A. 

Analyzes and quantifies NIH disease funding disparities by gender, comparing allocations to disease burden to highlight inequities in research funding priorities.

Gender Equality in Science, Medicine, and Global Health: Where Are We At and Why Does It Matter?

Shannon, G. et al.

Summarizes evidence and data on gender equality in science, medicine, and global health, highlighting progress, challenges, and implications for health outcomes.

Gender Norms and Health: Insights from Global Survey Data

Weber, A. M. et al.

Six case studies showed that: (1) gender norms are complex and can intersect with other social factors to impact health over the life course; (2) early gender-normative influences by parents and peers can have multiple and differing health consequences for girls and boys; (3) non-conformity with, and transgression of, gender norms can be harmful to health, particularly when they trigger negative sanctions; and (4) the impact of gender norms on health can be context-specific, demanding care when designing effective gender-transformative health policies and programmes.